|
|
negative regulation of glomerulus development
|
GO:0090194 |
2 |
0.270
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.252
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.134
|
Human |
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.092
|
|
|
|
negative regulation of cell proliferation involved in kidney development
|
GO:1901723 |
2 |
0.091
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.090
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.088
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.084
|
Human |
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.084
|
Human |
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.081
|
Human |
|
|
negative regulation of kidney development
|
GO:0090185 |
2 |
0.072
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.071
|
Mouse |
|
|
secretion by cell
|
GO:0032940 |
226 |
0.067
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.066
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.056
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.053
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.052
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.050
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.050
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.046
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.046
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.044
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.044
|
|
|
|
sex determination
|
GO:0007530 |
3 |
0.044
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.044
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.043
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.042
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.042
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.041
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.041
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.041
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.040
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.039
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.038
|
Human |
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.038
|
Human |
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.038
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.038
|
|
|
|
regulation of male gonad development
|
GO:2000018 |
4 |
0.037
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.036
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.036
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.036
|
Human |
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.036
|
Human |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.035
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.035
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.034
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.034
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.034
|
Human |
|
|
immune response
|
GO:0006955 |
307 |
0.033
|
|
|
|
ribonucleoprotein complex biogenesis
|
GO:0022613 |
116 |
0.033
|
Mouse |
|
|
response to other organism
|
GO:0051707 |
261 |
0.032
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.032
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.031
|
|
|
|
positive regulation of male gonad development
|
GO:2000020 |
3 |
0.030
|
|
|
|
regulation of heart growth
|
GO:0060420 |
4 |
0.030
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.030
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.030
|
Human |
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.030
|
|
|
|
negative regulation of glomerular mesangial cell proliferation
|
GO:0072125 |
2 |
0.029
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.029
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.029
|
Human |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.028
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.028
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.028
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.028
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.028
|
Human |
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.027
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.027
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.027
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.027
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.026
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.026
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.026
|
Human |
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
89 |
0.026
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.026
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.026
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.025
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.025
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.025
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.025
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.025
|
|
|
|
diaphragm development
|
GO:0060539 |
2 |
0.025
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.025
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
62 |
0.024
|
Human |
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.024
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.024
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.024
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.024
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.024
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.023
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.023
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.023
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.023
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
64 |
0.023
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.023
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.023
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.023
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.022
|
|
|
|
metanephric s shaped body morphogenesis
|
GO:0072284 |
4 |
0.022
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.022
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.022
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.022
|
Human |
|
|
embryo development
|
GO:0009790 |
123 |
0.022
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.022
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.022
|
|
|
|
rna splicing
|
GO:0008380 |
131 |
0.022
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.022
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.022
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.021
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.021
|
|
|
|
regulation of glomerulus development
|
GO:0090192 |
3 |
0.021
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.021
|
Human |
|
|
response to hormone
|
GO:0009725 |
175 |
0.021
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.021
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
54 |
0.021
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.021
|
|
|
|
growth
|
GO:0040007 |
202 |
0.021
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.020
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.020
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.020
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.020
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.020
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.020
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.020
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.020
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.020
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.020
|
|
|
|
mitochondrial rna metabolic process
|
GO:0000959 |
15 |
0.020
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.020
|
Human |
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.020
|
|
|
|
maturation of 5 8s rrna from tricistronic rrna transcript ssu rrna 5 8s rrna lsu rrna
|
GO:0000466 |
2 |
0.019
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.019
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.019
|
|
|
|
regulation of glomerular mesangial cell proliferation
|
GO:0072124 |
3 |
0.019
|
|
|
|
blastocyst formation
|
GO:0001825 |
3 |
0.019
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.018
|
Human |
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.018
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.018
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.018
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.018
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.018
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.018
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.018
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.018
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.017
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.017
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.017
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.017
|
|
|
|
rna phosphodiester bond hydrolysis
|
GO:0090501 |
35 |
0.017
|
Human |
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.017
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.017
|
Human |
|
|
epithelium development
|
GO:0060429 |
227 |
0.017
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
50 |
0.017
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.017
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.017
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.017
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.017
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.017
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.016
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.016
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.016
|
|
|
|
cardiac muscle cell fate commitment
|
GO:0060923 |
4 |
0.016
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.016
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.016
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.016
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.016
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.016
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.016
|
Human |
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.015
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.015
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.015
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.015
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.015
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.015
|
Human |
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.015
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.015
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
2 |
0.015
|
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
40 |
0.015
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.015
|
Human |
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.015
|
Human |
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.015
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.015
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.015
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.015
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.015
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.015
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.014
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.014
|
|
|
|
translation
|
GO:0006412 |
132 |
0.014
|
Human |
|
|
regulation of mesonephros development
|
GO:0061217 |
3 |
0.014
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.014
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
80 |
0.014
|
Human |
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.014
|
|
|
|
protein secretion
|
GO:0009306 |
98 |
0.014
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.014
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.014
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.014
|
|
|
|
protein dna complex assembly
|
GO:0065004 |
64 |
0.014
|
Human |
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.014
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.013
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.013
|
Human |
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.013
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.013
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.013
|
|
|
|
myosin filament organization
|
GO:0031033 |
2 |
0.013
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.013
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.013
|
Human |
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.013
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.013
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.013
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.013
|
|
|
|
mitochondrial transport
|
GO:0006839 |
60 |
0.013
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.013
|
|
|
|
organic anion transport
|
GO:0015711 |
103 |
0.013
|
|
|
|
glomerular mesangial cell proliferation
|
GO:0072110 |
3 |
0.013
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.013
|
|
|
|
rrna metabolic process
|
GO:0016072 |
40 |
0.013
|
Mouse |
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.012
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.012
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.012
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.012
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.012
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.012
|
Human |
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.012
|
Human |
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.012
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.012
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.012
|
Human |
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.012
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.012
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.012
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.012
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.012
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.012
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
35 |
0.012
|
|
|
|
protein tetramerization
|
GO:0051262 |
47 |
0.012
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.012
|
|
|
|
pericardium development
|
GO:0060039 |
2 |
0.012
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.012
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
72 |
0.012
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.012
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.012
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.012
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.012
|
|
|
|
establishment of protein localization to mitochondrion
|
GO:0072655 |
22 |
0.012
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
90 |
0.011
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.011
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.011
|
Human |
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.011
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.011
|
|
|
|
cell chemotaxis
|
GO:0060326 |
112 |
0.011
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.011
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.011
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.011
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.011
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.011
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.011
|
|
|
|
defense response to virus
|
GO:0051607 |
71 |
0.011
|
|
|
|
dna replication
|
GO:0006260 |
116 |
0.011
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.011
|
|
|
|
ncrna metabolic process
|
GO:0034660 |
108 |
0.011
|
Mouse |
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.011
|
|
|
|
male sex differentiation
|
GO:0046661 |
25 |
0.011
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.011
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.011
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.011
|
|
|
|
cell proliferation involved in kidney development
|
GO:0072111 |
3 |
0.011
|
|
|
|
positive regulation of translation
|
GO:0045727 |
35 |
0.011
|
Human |
|
|
epithelial cell fate commitment
|
GO:0072148 |
3 |
0.011
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.011
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.011
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.011
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
114 |
0.011
|
|
|
|
methylation
|
GO:0032259 |
106 |
0.011
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.011
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.011
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.010
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.010
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
53 |
0.010
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.010
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.010
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.010
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.010
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.010
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.010
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.010
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.010
|
|
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.010
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.010
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.010
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.010
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.010
|
Human |
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.010
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
73 |
0.010
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.010
|
|
|
|
lipid localization
|
GO:0010876 |
106 |
0.010
|
|
|
|
mrna processing
|
GO:0006397 |
133 |
0.010
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
2 |
0.010
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.010
|
|